Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Initial Drug Administration	STARTED	Flutamide Alone	33
Initial Drug Administration	STARTED	Flutamide + Vaccine + Sargramostim	31
Initial Drug Administration	COMPLETED	Flutamide Alone	33
Initial Drug Administration	COMPLETED	Flutamide + Vaccine + Sargramostim	31
Initial Drug Administration	NOT COMPLETED	Flutamide Alone	0
Initial Drug Administration	NOT COMPLETED	Flutamide + Vaccine + Sargramostim	0
Progressed to Receive Vaccine Alone	STARTED	Flutamide Alone	11
Progressed to Receive Vaccine Alone	STARTED	Flutamide + Vaccine + Sargramostim	0
Progressed to Receive Vaccine Alone	COMPLETED	Flutamide Alone	11
Progressed to Receive Vaccine Alone	COMPLETED	Flutamide + Vaccine + Sargramostim	0
Progressed to Receive Vaccine Alone	NOT COMPLETED	Flutamide Alone	0
Progressed to Receive Vaccine Alone	NOT COMPLETED	Flutamide + Vaccine + Sargramostim	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00450463/flow